Novanta (0VAG) Stock Overview
Provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
0VAG Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Novanta Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$134.28 |
| 52 Week High | US$152.47 |
| 52 Week Low | US$99.31 |
| Beta | 1.6 |
| 1 Month Change | 12.30% |
| 3 Month Change | 21.08% |
| 1 Year Change | -9.58% |
| 3 Year Change | -5.03% |
| 5 Year Change | 5.33% |
| Change since IPO | 124.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0VAG | GB Electronic | GB Market | |
|---|---|---|---|
| 7D | 1.8% | 2.0% | 1.0% |
| 1Y | -9.6% | 24.1% | 20.6% |
Return vs Industry: 0VAG underperformed the UK Electronic industry which returned 24.1% over the past year.
Return vs Market: 0VAG underperformed the UK Market which returned 20.6% over the past year.
Price Volatility
| 0VAG volatility | |
|---|---|
| 0VAG Average Weekly Movement | 7.4% |
| Electronic Industry Average Movement | 6.0% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 2.5% |
Stable Share Price: 0VAG's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: 0VAG's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 3,000 | Matthijs Glastra | www.novanta.com |
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles.
Novanta Inc. Fundamentals Summary
| 0VAG fundamental statistics | |
|---|---|
| Market cap | US$4.81b |
| Earnings (TTM) | US$52.82m |
| Revenue (TTM) | US$960.31m |
Is 0VAG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0VAG income statement (TTM) | |
|---|---|
| Revenue | US$960.31m |
| Cost of Revenue | US$527.29m |
| Gross Profit | US$433.02m |
| Other Expenses | US$380.20m |
| Earnings | US$52.82m |
Last Reported Earnings
Sep 26, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.48 |
| Gross Margin | 45.09% |
| Net Profit Margin | 5.50% |
| Debt/Equity Ratio | 56.3% |
How did 0VAG perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/19 14:42 |
| End of Day Share Price | 2026/01/16 00:00 |
| Earnings | 2025/09/26 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Novanta Inc. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Mason | Baird |
| Andrew Buscaglia | Berenberg |
| Lee Jagoda | CJS Securities, Inc. |